Back to Search
Start Over
ICER's Revised Value Assessment Framework for 2017-2019: A Critique.
- Source :
-
PharmacoEconomics [Pharmacoeconomics] 2017 Oct; Vol. 35 (10), pp. 977-980. - Publication Year :
- 2017
- Subjects :
- Cost-Benefit Analysis
Humans
Quality-Adjusted Life Years
Technology Assessment, Biomedical economics
Technology Assessment, Biomedical trends
United States
Drug Costs standards
Technology Assessment, Biomedical methods
Technology, Pharmaceutical economics
Technology, Pharmaceutical trends
Subjects
Details
- Language :
- English
- ISSN :
- 1179-2027
- Volume :
- 35
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- PharmacoEconomics
- Publication Type :
- Editorial & Opinion
- Accession number :
- 28791663
- Full Text :
- https://doi.org/10.1007/s40273-017-0560-y